Impact of 13-valent pneumococcal conjugate vaccine on laboratory-confirmed pneumococcal meningitis and purulent meningitis among children ˂5 years in Cameroon, 2011–2018

BACKGROUND: The 13-valent pneumococcal conjugate vaccine (PCV13) entered Cameroon’s childhood national immunization programme (NIP) in July 2011 under a 3-dose schedule (6, 10, 14 weeks of age) without any catch-up. We described the impact of PCV13 onserotype distribution among pneumococcal meningit...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PLoS One
Hauptverfasser: Njuma Libwea, John, A. Fletcher, Mark, Koki Ndombo, Paul, Boula, Angeline, Ashukem, Nadesh Taku, Ngo Baleba, Madeleine, Kingue Bebey, Rachel Sandrine, Nkolo Mviena, Eric Gaston, Tageube, Jean, Kobela Mbollo, Marie, Koulla-Shiro, Sinata, Madhi, Shabir, Njanpop-Lafourcade, Berthe-Marie, Mohammad, Ali, Begier, Elizabeth, Southern, Joanna, Beavon, Rohini, Gessner, Bradford
Format: Artigo
Sprache:Inglês
Veröffentlicht: Public Library of Science 2021
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8049353/
https://ncbi.nlm.nih.gov/pubmed/33857235
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0250010
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge